Aberrant methylation of tRNAs links cellular stress to neuro-developmental disorders.
Blanco S, Dietmann S, Flores JV, Hussain S, Kutter C, Humphreys P, Lukk M, Lombard P, Treps L, Popis M, Kellner S, Hölter SM, Garrett L, Wurst W, Becker L, Klopstock T, Fuchs H, Gailus-Durner V, Hrabĕ de Angelis M, Káradóttir RT, Helm M, Ule J, Gleeson JG, Odom DT, Frye M. · 2014
Read Aberrant methylation of tRNAs links cellular stress to neuro-developmental disorders. by Blanco S, Dietmann S, Flores JV, Hussain S, Kutter C, Humphreys P, Lukk M, Lombard P, Treps L, Popis M, Kellner S, Hölter SM, Garrett L, Wurst W, Becker L, Klopstock T, Fuchs H, Gailus-Durner V, Hrabĕ de Angelis M, Káradóttir RT, Helm M, Ule J, Gleeson JG, Odom DT, Frye M. (2014) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4195770.txt.
Introduction
Sandra Blanco and a team of eleven co-authors linked a missing RNA mark to brain disorders in The EMBO Journal in 2014. Mutations in NSun2, an enzyme that adds a chemical mark to RNA, cause small head size and learning problems in people and mice. How losing the mark harms the brain was unclear.
Comparing patient cells and mice lacking NSun2, the team found unmarked transfer RNAs get cut by the enzyme angiogenin, and the fragments pile up. Those fragments slow protein production and switch on stress responses, shrinking cells and killing neurons in the cortex, hippocampus, and striatum. Blocking angiogenin in the womb eased the brain's stress sensitivity. The work frames the disease as a stress problem sparked by broken RNA.
Catalog record
| CREATOR | Blanco S, Dietmann S, Flores JV, Hussain S, Kutter C, Humphreys P, Lukk M, Lombard P, Treps L, Popis M, Kellner S, Hölter SM, Garrett L, Wurst W, Becker L, Klopstock T, Fuchs H, Gailus-Durner V, Hrabĕ de Angelis M, Káradóttir RT, Helm M, Ule J, Gleeson JG, Odom DT, Frye M. |
|---|---|
| YEAR | 2014 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 102 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Aberrant methylation of tRNAs links cellular stress to neuro-developmental disorders By Sandra Blanco, Sabine Dietmann, Joana V Flores, Shobbir Hussain, Claudia Kutter, Peter Humphreys, Margus Lukk, Patrick Lombard, Lucas Treps, Martyna Popis, Stefanie Kellner, Sabine M Hölter Published in: The EMBO Journal DOI: 10.15252/embj.201489282 ABSTRACT Abstract Mutations in the cytosine-5 RNA methyltransferase NSun2 cause microcephaly and other neurological abnormalities in mice and human. How post-transcriptional methylation contributes to the human disease is currently unknown. By comparing gene expression data with global cytosine-5 RNA methylomes in patient fibroblasts and NSun2-deficient mice, we find that loss of cytosine-5 RNA methylation increases the angiogenin-mediated endonucleolytic cleavage of transfer RNAs (tRNA) leading to an accumulation of 5′ tRNA-derived small RNA fragments. Accumulation of 5′ tRNA fragments in the absence of NSun2 reduces protein translation rates and activates stress pathways leading to reduced cell size and increased apoptosis of cortical, hippocampal and striatal neurons. Mechanistically, we demonstrate that angiogenin binds with higher affinity to tRNAs lacking site-specific NSun2-mediated methylation and that the presence of 5′ tRNA fragments is sufficient and required to trigger cellular stress responses. Furthermore, the enhanced sensitivity of NSun2-deficient brains to oxidative stress can be rescued through inhibition of angiogenin during embryogenesis. In conclusion, failure in NSun2-mediated tRNA methylation contributes to human diseases via stress-induced RNA cleavage. Keywords: 5-methylcytidine, Misu, NSun2, RNA modification See also: G Stoecklin & S Diederichs (September 2014) INTRODUCTION Hereditary forms of intellectual disability (ID) are neuro-developmental disorders with a worldwide prevalence of around 2% (Ropers, 2008; de Ligt et al, 2012). Several genetic mutations in the NSUN2 gene have been identified to cause a syndromic form of intellectual disability and a Dubowitz-like syndrome in humans (Abbasi-Moheb et al, 2012; Khan et al, 2012; Martinez et al, 2012). In individuals with the Dubowitz-like syndrome, the NSUN2 gene carries a homozygous mutation in the canonical splice acceptor site of exon 6 leading to a truncation of the transcribed mRNA and loss of the NSun2 protein (Martinez et al, 2012). Besides ID, the patients show further symptoms of neurological abnormalities such as microcephaly, behavioural deficits, speech delay, abnormal gait as well as morphological features including growth retardation, unusual facies and cutaneous abnormalities (Dubowitz, 1965; Huber et al, 2011; Martinez et al, 2012). While some of the morphological symptoms are also present in loss-of-function transgenic mouse models for NSun2, neurological defects have not been studied yet (Blanco et al, 2011). However, loss of the NSun2 orthologue in Drosophila causes severe short-term memory deficits (Abbasi-Moheb et al, 2012). It is known that NSun2 is a conserved RNA methyltransferase that modifies cytosine-5 in transfer RNAs (tRNAs) and other non-coding RNA species (Brzezicha et al, 2006; Frye & Watt, 2006; Blanco et al, 2011; Hussain et al, 2013b; Khoddami & Cairns, 2013), but whether and how loss of RNA methylation can cause symptoms of these complex diseases is currently unknown. Although cytosine-5 methylation (m5C) is one of the best characterised epigenetic modifications found in DNA (Suzuki & Bird, 2008), the cellular and molecular functions of the same modified nucleobase in RNA remain unclear. Deletion of cytosine-5 tRNA methyltransferases in yeast, flies, fish and mice is not lethal (Wu et al, 1998; Goll et al, 2006; Rai et al, 2007; Chernyakov et al, 2008; Blanco et al, 2011). However, loss of certain tRNA modifications can increase sensitivity to stress stimuli, including drugs, DNA damage or environmental cues (Wu et al, 1998; Jablonowski et al, 2006; Begley et al, 2007; Schaefer et al, 2010). The three currently known cytosine-5 tRNA methyltransferases in higher eukaryotes are NSun2, NSun4 and Dnmt2 (Brzezicha et al, 2006; Frye & Watt, 2006; Schaefer et al, 2010; Blanco et al, 2011; Tuorto et al, 2012; Metodiev et al, 2014). While NSun4 ablation is lethal in mice, Dnmt2-deficient mice do not exhibit any gross phenotype (Goll et al, 2006; Metodiev et al, 2014). Deletion of NSun2 alone or in combination with Dnmt2 can impair cellular differentiation pathways in skin, testes and brain (Rai et al, 2007; Blanco et al, 2011; Tuorto et al, 2012; Hussain et al, 2013c). Lack of Dnmt2-mediated methylation in flies increases stress-induced cleavage of tRNAs and sensitises flies to oxidative stress in vivo (Schaefer et al, 2010). In humans, stress-induced tRNA cleavage is mediated by angiogenin and although Dnmt2 methylation protects tRNAs from angiogenin cleavage in vitro, its biological function in humans has yet to be identified (Yamasaki et al, 2009; Schaefer et al, 2010). Together, these data provide compelling evidence that site-specific methylation of tRNAs protects from angiogenin-mediated cleavage. However, it is currently unknown how non-Dnmt2-targeted tRNAs are protected from cleavage. Dnmt2-mediated methylation is specific to the three tRNAs GlyGCC, AspGTC and ValAAC (Schaefer et al, 2010; Tuorto et al, 2012; Khoddami & Cairns, 2013), yet all tRNA isoacceptors can be cleaved. So far, no human disease has been associated with mutations in Dnmt2, but similar to NSun2, also mutations in angiogenin are linked to neurological disorders (van Es et al, 2011). Neuro-developmental and intellectual disabilities are further commonly associated with oxidative stress (Wu et al, 2007; De Felice et al, 2012; Lintas et al, 2012). Here, we set out to answer the fundamental question how hypo-methylated RNA can cause human neurological disorders. By combining genome-wide methylation approaches with in vitro and in vivo assays in NSun2 knockout mouse models and cells obtained from individuals with Dubowitz-like syndrome, we show that cytosine-5 tRNA methylation is a very common modification and is required to mediate cellular survival during stress responses. We reveal that fragmentation of tRNAs into short non-coding RNAs is perturbed in mouse and patient cells lacking the NSun2 protein, and identify aberrant accumulation of cleaved tRNAs as one mechanism by which mutations in a RNA methyltransferase can result in neurological abnormalities in mice and humans. RESULTS Cytosine-5 methylation is a common modification in actively transcribed tRNAs Recent high-throughput RNA methylation profiling identified tRNAs as the most common cytosine-5 methylated RNA species (Squires et al, 2012; Hussain et al, 2013b; Khoddami & Cairns, 2013). However, the identification of the specific methylated tRNAs has proven difficult because there are over 400 predicted tRNA genes in the mammalian genome, which are highly similar and repetitive in DNA sequence (Lowe & Eddy, 1997). Our first aim was therefore to precisely map cytosine-5 methylation in actively transcribed tRNAs, in mouse and human tissues expressing and lacking NSun2 (Supplementary Fig S1A) (Blanco et al, 2011; Martinez et al, 2012). To identify actively transcribed tRNA genes, we first performed Pol III chromatin immunoprecipitation followed by DNA sequencing (ChIP-seq) and then validated tRNA expression by sequencing cDNA from total RNA (Supplementary Fig S1B). Finally, to determine NSun2 site-specific occurrence of cytosine-5 methylation in tRNA, we performed RNA bisulphite sequencing and miCLIP (Supplementary Fig S1B). We identified a total of 252 actively transcribed tRNA genes in mouse skin, which highly overlapped (80–90%) with tRNA gene expression in mouse liver, muscle and testis (Supplementary Fig S1C and Supplementary Table S1) (Kutter et al, 2011). When NSun2 was deleted, the number of mature tRNAs was largely unaffected and Pol III occupancy to tRNAs remained unchanged (Supplementary Fig S1D and E; Supplementary Table S2). Bisulphite sequencing and miCLIP revealed that the vast majority (77%) of actively transcribed tRNAs were